Department of Neurophysiology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Acta Neurol Scand. 2010 Nov;122(5):323-8. doi: 10.1111/j.1600-0404.2009.01306.x.
Evaluation of pulmonary function in patients with spinocerebellar ataxias (SCA) 1, 2 and 3 without clinical evidence of pulmonary dysfunction.
Thirty patients (F:M = 7:23; age: 35 ± 11.3 years; SCA1 - 13, SCA2 - 9 and SCA3 - 8) without clinical manifestations of respiratory dysfunction and 30 controls underwent pulmonary function tests. The percentage predicted values of forced vital capacity (FVC), volume of air exhaled during first second of FVC (FEV1), peak expiratory flow rate (PEFR) and maximal voluntary ventilation (MVV), actual values of maximal inspiratory and expiratory pressures (MIP and MEP in mmHg), and ratios of actual values of FEV1/FVC (%) and FEV1/PEFR (ml/l/min) were analyzed.
Compared with controls SCA patients had significant reductions of FVC (71.1 ± 17.5 vs 85.5 ± 18.7; P < 0.01), PEFR (51.5 ± 20.7 vs 77.1 ± 24.9; P < 0.001), MVV (64.4 ± 21.6 vs 97.2 ± 22.7; P < 0.001), MIP (27.7 ± 16.8 vs 50.1 ± 15.1; P < 0.001) and MEP (38.1 ± 18.7 vs 74.7 ± 16.0; P < 0.001), elevation of FEV1/PEFR (10.5 ± 2.8 vs 7.4 ± 2.1; P < 0.001), but no significant change of FEV1 and FEV1/FVC. FEV1/PEFR correlated positively with illness duration and MVV negatively with severity of illness.
The present study showed subclinical restrictive type of pulmonary dysfunction in SCA, and possible presence of upper airway obstruction. Chest physiotherapy and breathing exercises should be introduced early in management of SCA.
评估无肺部功能障碍临床证据的脊髓小脑共济失调(SCA)1、2 和 3 型患者的肺功能。
30 例患者(F:M=7:23;年龄:35±11.3 岁;SCA1-13 例、SCA2-9 例和 SCA3-8 例)无呼吸功能障碍的临床表现,且 30 例对照者进行了肺功能检查。用力肺活量(FVC)预计百分比值、FVC 第一秒呼气量(FEV1)、呼气峰流速(PEFR)和最大自主通气量(MVV)、实际最大吸气和呼气压力(MIP 和 MEP,mmHg)值、FEV1/FVC(%)和 FEV1/PEFR(ml/l/min)的实际值比进行了分析。
与对照组相比,SCA 患者的 FVC(71.1±17.5 对 85.5±18.7;P<0.01)、PEFR(51.5±20.7 对 77.1±24.9;P<0.001)、MVV(64.4±21.6 对 97.2±22.7;P<0.001)、MIP(27.7±16.8 对 50.1±15.1;P<0.001)和 MEP(38.1±18.7 对 74.7±16.0;P<0.001)均显著降低,FEV1/PEFR(10.5±2.8 对 7.4±2.1;P<0.001)升高,但 FEV1 和 FEV1/FVC 无显著变化。FEV1/PEFR 与疾病持续时间呈正相关,而 MVV 与疾病严重程度呈负相关。
本研究显示 SCA 存在亚临床限制性肺功能障碍,可能存在上气道阻塞。胸部物理治疗和呼吸锻炼应在 SCA 管理中尽早引入。